Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shengxiang Ge

Showing results (151-160 of 158) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 158 results.
The Lancet Regional Health. Western Pacific|September 16, 2021
Comparison of detection strategies for screening and confirming congenital cytomegalovirus infection in newborns in a highly seroprevalent population: a mother-child cohort studyYue Huang, Han Wang, Tingdong Li, et al.
The New England Journal of Medicine|August 30, 2023
Anti-Epstein-Barr Virus BNLF2b for Mass Screening for Nasopharyngeal CancerTingdong Li, Fugui Li, Xiaoyi Guo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2020
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019Juanjuan Zhao, Quan Yuan, Haiyan Wang, et al.
Signal Transduction and Targeted Therapy|April 1, 2021
Gender associates with both susceptibility to infection and pathogenesis of SARS-CoV-2 in Syrian hamsterLunzhi Yuan, Huachen Zhu, Ming Zhou, et al.
Signal Transduction and Targeted Therapy|May 3, 2024
Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effectsRao Fu, Ruoyao Qi, Hualong Xiong, et al.
Lancet (London, England)|February 22, 2024
Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trialShoujie Huang, Xuefeng Zhang, Yingying Su, et al.
Small Methods|February 22, 2021
Virus-Free and Live-Cell Visualizing SARS-CoV-2 Cell Entry for Studies of Neutralizing Antibodies and Compound InhibitorsYali Zhang, Shaojuan Wang, Yangtao Wu, et al.
Nature Communications|July 11, 2023
Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamstersLiang Zhang, Yao Jiang, Jinhang He, et al.
Pageof 16

Showing results (151-160 of 158) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 158 results.
The Lancet Regional Health. Western Pacific|September 16, 2021
Comparison of detection strategies for screening and confirming congenital cytomegalovirus infection in newborns in a highly seroprevalent population: a mother-child cohort studyYue Huang, Han Wang, Tingdong Li, et al.
The New England Journal of Medicine|August 30, 2023
Anti-Epstein-Barr Virus BNLF2b for Mass Screening for Nasopharyngeal CancerTingdong Li, Fugui Li, Xiaoyi Guo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2020
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019Juanjuan Zhao, Quan Yuan, Haiyan Wang, et al.
Signal Transduction and Targeted Therapy|April 1, 2021
Gender associates with both susceptibility to infection and pathogenesis of SARS-CoV-2 in Syrian hamsterLunzhi Yuan, Huachen Zhu, Ming Zhou, et al.
Signal Transduction and Targeted Therapy|May 3, 2024
Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effectsRao Fu, Ruoyao Qi, Hualong Xiong, et al.
Lancet (London, England)|February 22, 2024
Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trialShoujie Huang, Xuefeng Zhang, Yingying Su, et al.
Small Methods|February 22, 2021
Virus-Free and Live-Cell Visualizing SARS-CoV-2 Cell Entry for Studies of Neutralizing Antibodies and Compound InhibitorsYali Zhang, Shaojuan Wang, Yangtao Wu, et al.
Nature Communications|July 11, 2023
Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamstersLiang Zhang, Yao Jiang, Jinhang He, et al.
Pageof 16